Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 May;72(2):207–210.

Lymphocyte and IgG responses to different herpes simplex virus antigens in patients with frequent HSV-1 reactivations.

P Ljungman 1, L Zetterqvist 1, V A Sundqvist 1, S Jeansson 1, A Heimdahl 1, B Wahren 1
PMCID: PMC1541547  PMID: 2842095

Abstract

Seventeen patients with a history of frequent clinical herpes simplex (HSV) reactivations and 13 HSV seropositive controls were monitored for 6 months. The patients had 4-8 clinical reactivations during the study. No clinical HSV reactivations were observed in the controls. IgG subclasses directed against HSV-1 nucleocapsid, membrane and glycoprotein C (gC) antigens were determined after the study period. Anti-HSV IgG4 directed against gC was found more often in the patients (65%) than in the controls (8%, P less than 0.025). The same trend was seen for IgG4 against HSV nucleocapsid antigen (88 and 46%, n.s.) and HSV membrane antigen (82 and 38%, n.s.). In both patients and controls IgG3 was found more often against nucleocapsid antigen compared to membrane or gC antigens (P less than 0.001). Lymphocytes were stimulated with the different antigens and the anti-HSV IgG subclass responses and cellular proliferation were determined. Lymphocyte produced IgG4 against HSV nucleocapsid antigen was found more often in patients than in controls (47 and 8%, P = 0.05) and membrane antigen (41 and 0%; P less than 0.025). No differences were found in the magnitude of lymphocyte proliferation responses between patients and controls. Lymphocyte proliferation responses were stronger to nucleocapsid antigen than to membrane or gC antigens (P less than 0.01).

Full text

PDF
207

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ansorg R. A., Knoche M. E., Spies A. F., Kraus C. J. Differentiation of the major flagellar antigens of Pseudomonas aeruginosa by the slide coagglutination technique. J Clin Microbiol. 1984 Jul;20(1):84–88. doi: 10.1128/jcm.20.1.84-88.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Borysiewicz L. K., Morris S., Page J. D., Sissons J. G. Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity. Eur J Immunol. 1983 Oct;13(10):804–809. doi: 10.1002/eji.1830131005. [DOI] [PubMed] [Google Scholar]
  3. Coleman R. M., Nahmias A. J., Williams S. C., Phillips D. J., Black C. M., Reimer C. B. IgG subclass antibodies to herpes simplex virus. J Infect Dis. 1985 May;151(5):929–936. doi: 10.1093/infdis/151.5.929. [DOI] [PubMed] [Google Scholar]
  4. Heber-Katz E., Hollosi M., Dietzschold B., Hudecz F., Fasman G. D. The T cell response to the glycoprotein D of the herpes simplex virus: the significance of antigen conformation. J Immunol. 1985 Aug;135(2):1385–1390. [PubMed] [Google Scholar]
  5. Jeansson S., Elwing H., Nygren H., Olofsson S. Evaluation of solubilized herpes simplex virus membrane antigens in diffusion in gel-enzyme-linked immunosorbent assay (DIG-ELISA). J Virol Methods. 1982 Apr;4(3):167–176. doi: 10.1016/0166-0934(82)90045-3. [DOI] [PubMed] [Google Scholar]
  6. Linde G. A., Hammarström L., Persson M. A., Smith C. I., Sundqvist V. A., Wahren B. Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections. Infect Immun. 1983 Oct;42(1):237–244. doi: 10.1128/iai.42.1.237-244.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ljungman P., Lönnqvist B., Gahrton G., Ringdén O., Wahren B. Cytomegalovirus-specific lymphocyte proliferation and in vitro cytomegalovirus IgG synthesis for diagnosis of cytomegalovirus infections after bone marrow transplantation. Blood. 1986 Jul;68(1):108–112. [PubMed] [Google Scholar]
  8. Ljungman P., Wahren B., Sundqvist V. A. Lymphocyte proliferation and IgG production with herpesvirus antigens in solid phase. J Virol Methods. 1985 Dec;12(3-4):199–208. doi: 10.1016/0166-0934(85)90130-2. [DOI] [PubMed] [Google Scholar]
  9. Olofsson S., Sjöblom I., Lundström M., Jeansson S., Lycke E. Glycoprotein C of herpes simplex virus type 1: characterization of O-linked oligosaccharides. J Gen Virol. 1983 Dec;64(Pt 12):2735–2747. doi: 10.1099/0022-1317-64-12-2735. [DOI] [PubMed] [Google Scholar]
  10. Steele R. W., Vincent M. M., Hensen S. A., Fuccillo D. A., Chapa I. A., Canales L. Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line. J Infect Dis. 1975 May;131(5):528–534. doi: 10.1093/infdis/131.5.528. [DOI] [PubMed] [Google Scholar]
  11. Sundqvist V. A. Frequency and specificity of varicella zoster virus IgM response. J Virol Methods. 1982 Nov;5(3-4):219–227. doi: 10.1016/0166-0934(82)90012-x. [DOI] [PubMed] [Google Scholar]
  12. Sundqvist V. A., Wahren B. An interchangeable ELISA for cytomegalovirus antigen and antibody. J Virol Methods. 1981 Apr;2(5):301–312. doi: 10.1016/0166-0934(81)90029-x. [DOI] [PubMed] [Google Scholar]
  13. Torseth J. W., Cohen G. H., Eisenberg R. J., Berman P. W., Lasky L. A., Cerini C. P., Heilman C. J., Kerwar S., Merigan T. C. Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses. J Virol. 1987 May;61(5):1532–1539. doi: 10.1128/jvi.61.5.1532-1539.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wahren B., Linde A., Sundqvist V. A., Ljungman P., Lönnqvist B., Ringdén O. IgG-subclass-specific CMV reactivity in bone marrow transplant recipients. Transplantation. 1984 Nov;38(5):479–483. doi: 10.1097/00007890-198411000-00007. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES